| Detected | Trial | Change |
|---|---|---|
| 2026-07-24 | NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With… |
critical Trial terminated |
| 2026-07-24 | NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With… |
Enrollment reduced: 204 -> 12 participants |
| 2026-07-24 | NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With… |
date change Primary completion moved earlier: 2028-08 -> 2025-01-13 |
| 2026-07-24 | NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With… |
date change Completion moved earlier: 2028-08 -> 2025-01-13 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-28 | NCT07730515 Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated… | Phase 1/2 | Recruiting |
| 2026-07-28 | NCT07730580 Study of XNW5004 Tablets in Advanced Prostate Cancer | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06776952 | A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients… | Relapsed/Refractory Peripheral T Cell Lymphoma | Recruiting |
| Phase 2 | |||
| NCT07545603 | Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular… | Follicular Lymphoma, Grade 1 | Recruiting |
| NCT06702605 | To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell… | Relapsed/Refractory Peripheral T Cell Lymphoma | Not Yet Recruiting |
| NCT07730580 | Study of XNW5004 Tablets in Advanced Prostate Cancer | Advanced Prostate Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06702995 | Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic… | Metastatic Castrate-Resistant Prostate Cancer | Recruiting |
| NCT06987500 | A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed… | Tumor, Solid | Recruiting |
| NCT06799637 | Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments | Advanced Solid Tumors | Recruiting |
| NCT07730515 | Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated… | Non-hodgkin Lymphoma | Recruiting |
| NCT07327294 | A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid… | Advanced Solid Tumors | Not Yet Recruiting |
| Phase 1 | |||
| NCT07707674 | Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic… | Metastatic Pancreatic Cancer | Not Yet Recruiting |